Up next

Autoplay

#22874 Comparison between Anticholinergic and Beta-3-adrenergic receptor agonist (Mirabegron) in...

0 Views • 08/24/25
Share
Side Effects
Side Effects
Subscribers
0

Comparison between Anticholinergic and Beta-3-adrenergic receptor agonist (Mirabegron) in Overactive Bladder-A systemic review

Wani M1, Masood S1

1. Medway Maritime Hospital

KEYWORDS: Overactive Bladder, Detrusor Overactivity, Pharmacology

This systemic review compared Anticholinergic medications with Beta-3- receptor agonist (Mirabegron) in management of patients with overactive bladder(OAB). The primary aim was to compare efficacy, adverse effects, persistence and adherence and cost effectiveness among these two groups of medications. Other properties considered included tolerability, effect in female OAB, combining two groups of medication in management of OAB.

Show more
0 Comments sort Sort By

Up next

Autoplay